These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. Sebrechts MM, Shaywitz SE, Shaywitz BA, Jatlow P, Anderson GM, Cohen DJ. Pediatrics; 1986 Feb; 77(2):222-8. PubMed ID: 3945535 [Abstract] [Full Text] [Related]
3. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Handen BL, Breaux AM, Gosling A, Ploof DL, Feldman H. Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682 [Abstract] [Full Text] [Related]
4. Effects of methylphenidate on hyperactive children's ability to sustain attention. Charles L, Schain RJ, Zelniker T, Guthrie D. Pediatrics; 1979 Oct; 64(4):412-8. PubMed ID: 492805 [Abstract] [Full Text] [Related]
5. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Lee SI, Hong SD, Kim SY, Kim EJ, Kim JH, Kim JH, Park MK, Park S, Park JH, Oh EY, Lim TS, Cheong S, Cho IH, Choi JW. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):210-6. PubMed ID: 17046131 [Abstract] [Full Text] [Related]
6. Methylphenidate hydrochloride given with or before breakfast: I. Behavioral, cognitive, and electrophysiologic effects. Swanson JM, Sandman CA, Deutsch C, Baren M. Pediatrics; 1983 Jul 30; 72(1):49-55. PubMed ID: 6866591 [Abstract] [Full Text] [Related]
8. Behavioral and stimulant treatment of hyperactive children: a therapy study with methylphenidate probes in a within-subject design. Pelham WE, Schnedler RW, Bologna NC, Contreras JA. J Appl Behav Anal; 1980 Jul 30; 13(2):221-36. PubMed ID: 7380749 [Abstract] [Full Text] [Related]
9. [The effects of psychostimulants on the cognitive results and behaviour of children with the combined subtype of attention deficit with hyperactivity]. Mulas F, Roselló B, Morant A, Hernández S, Pitarch I. Rev Neurol; 1980 Jul 30; 35(1):17-24. PubMed ID: 12389187 [Abstract] [Full Text] [Related]
10. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network. Arch Gen Psychiatry; 2005 Nov 30; 62(11):1266-74. PubMed ID: 16275814 [Abstract] [Full Text] [Related]
11. Methylphenidate dosing: twice daily versus three times daily. Stein MA, Blondis TA, Schnitzler ER, O'Brien T, Fishkin J, Blackwell B, Szumowski E, Roizen NJ. Pediatrics; 1996 Oct 30; 98(4 Pt 1):748-56. PubMed ID: 8885956 [Abstract] [Full Text] [Related]
12. Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Swanson J, Kinsbourne M, Roberts W, Zucker K. Pediatrics; 1978 Jan 30; 61(1):21-9. PubMed ID: 400817 [Abstract] [Full Text] [Related]
14. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Klassen AF, Miller A, Fine S. Pediatrics; 2004 Nov 30; 114(5):e541-7. PubMed ID: 15520087 [Abstract] [Full Text] [Related]
15. Testing the ability of children with attention deficit hyperactivity disorder to accurately report the effects of medication on their behavior. Ardoin SP, Martens BK. J Appl Behav Anal; 2000 Nov 30; 33(4):593-610. PubMed ID: 11214033 [Abstract] [Full Text] [Related]
19. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM, Earls MF. Pediatrics; 2005 Jan 30; 115(1):e97-104. PubMed ID: 15629972 [Abstract] [Full Text] [Related]